AMS — Advanced Medical Solutions Income Statement
0.000.00%
Last trade - 00:00- £426.01m
- £490.83m
- £228.94m
Annual income statement for Advanced Medical Solutions, fiscal year end - December 31st, GBP millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IFRS | IFRS | IFRS | IFRS | — |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 109 | 124 | 126 | 178 | 229 |
| Cost of Revenue | |||||
| Gross Profit | 61.1 | 73.4 | 70.1 | 92.6 | 122 |
| Selling / General / Administrative Expenses | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 85.6 | 99.4 | 107 | 166 | 206 |
| Operating Profit | 23 | 24.9 | 18.9 | 11.2 | 22.7 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 22 | 25.9 | 21.2 | 9.82 | 17.8 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 17.5 | 20.4 | 15.9 | 7.14 | 10.1 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | 17.5 | 20.4 | 15.9 | 7.09 | 9.95 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 17.5 | 20.4 | 15.9 | 7.09 | 9.95 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 0.08 | 0.093 | 0.072 | 0.092 | 0.077 |
| Dividends per Share |